Rohto Pharmaceutical Co.,Ltd. (TYO: 4527)

Market Cap	818.33B
Revenue (ttm)	278.03B
Net Income (ttm)	30.33B
Shares Out	228.14M
EPS (ttm)	132.56
PE Ratio	27.06
Forward PE	23.30
Dividend	33.00 (0.91%)
Ex-Dividend Date	Sep 27, 2024

Volume	614,300
Open	3,556.00
Previous Close	n/a
Day's Range	n/a
52-Week Range	2,640.50 - 4,117.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About Rohto Pharmaceutical Co.,Ltd.

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatologi...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1899
• Employees: 7,259
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4527

Financial Performance

In 2023, Rohto Pharmaceutical Co.,Ltd.'s revenue was 270.84 billion, an increase of 13.48% compared to the previous year's 238.66 billion. Earnings were 30.94 billion, an increase of 17.28%.